Peer-Reviewed Articles
- Watt, AD, Jenkins NL, McColl G, Collins S, Desmond P (2019). Ethical Issues in the Treatment of Late-Stage Alzheimer’s Disease. Journal of Alzheimer’s Disease 68(4), 1311-1316.
- Watt, AD, Jenkins NL, McColl G, Collins S, Desmond P (2019). “To Treat or not To Treat”: Informing the Decision for Disease-Modifying Therapy in Late-Stage Alzheimer’s Disease. Journal of Alzheimer’s Disease 68(4), 1321-1323.
- Watt, AD, Perez KA, Ang, CS O’Donnell, PO, Rembach, A, Perile, KK, Rumble, RL, Trounson, BO, Fowler, CJ, Faux, NG, Masters, CL, Villemagne VL, Barnham KJ (2014). Peripheral α-defensins 1 and 2 are elevated in Alzheimer’s disease. Journal of Alzheimer’s Disease 44(4), 803-810.
- Watt, AD, Crespi GAN, Down RA, Ascher DB, Gunn A, Perez KA, McLean CA, Villemagne VL, Parker MW, Barnham KJ, Miles LA (2014). Anti-Aβ antibodies target engagement: A response to Siemers et al. Acta neuropathologica 128 (4), 611-614.
- Watt, AD, Crespi GAN, Down RA, Ascher DB, Gunn A, Perez KA, McLean CA, Villemagne VL, Parker MW, Barnham KJ, Miles LA (2014). Do current therapeutic anti-Aβ antibodies for Alzheimer’s disease engage the target? Acta neuropathologica 127 (6), 803-810.
- Rembach, A, Watt AD, Wilson WJ, Rainey-Smith S, Ellis KA, Rowe CC, Villemagne VL, Bush AI, Martins RN, Ames D, Masters CL, Doecke JD (2014). An increased Neutrophil-Lymphocyte ratio in Alzheimer’s disease is a function of age and is weakly correlated with neocortical amyloid accumulation. Journal of Neuroimmunology 273 (1-2), 65-71.
- Watt, AD, Perez KA, Rembach A, Sherrat NA, Hung LW, Johanssen T, McLean CA, Kok WM, Hutton CA, Fodero-Tavoletti M, et al. (2013). Oligomers, fact or artefact? SDS-PAGE induces dimerization of beta-amyloid in human brain samples. Acta neuropathologica 125, 549-564.
- Rembach A, Faux NG, Watt AD, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Roberts BR, Perez KA, Li QX, Laws SM, Taddei K, Rainey-Smith S, Robertson JS, Vandijck M, Vanderstichele H, Barnham KJ, Ellis KA, Szoeke C, Macaulay L, Rowe CC, Villemagne VL, Ames D, Martins RN, Bush AI, Masters CL; AIBL research group. (2013). Changes in plasma amyloid beta in a longitudinal study of study and aging. Alzheimer’s and Dementia 10(1), 53-61.
- Rembach A, Ryan, TM, Roberts, BR, Doecke, JD, Wilson, WJ, Watt, AD, Barnham, KJ, Masters, CL (2013). Progress towards a consensus on biomarkers for Alzheimer’s disease: A review of peripheral based analytes. Biomarkers in Medicine. 7(4), 641-62.
- Watt, AD, Villemagne, VL, Barnham, KJ (2012). Metals membranes and Amyloid-β Oligomers: Key pieces in the Alzheimer’s disease puzzle? Journal of Alzheimer’s Disease. 31(1): p. 1-11.
- Watt, A.D., Perez, K.A., Rembach, A.R., Masters, C.L., Villemagne, V.L., and Barnham, K.J. (2012). Variability in blood-based amyloid-beta assays: the need for consensus on pre-analytical processing. Journal of Alzheimer’s Disease 30, 323-336.
- Rembach A, Doecke JD, Roberts BR, Watt AD, Faux NG, Volitakis I, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Wilson W, Ellis KA, Martins RN, Rowe CC, Villemagne VL, Ames D, Masters CL, Bush AI (2012). Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer’s disease. Journal of Alzheimer’s Disease. 34(1): p. 171-182.
- Watt, AD, Perez, KA, Hung, LW (2011). Elucidating the Role of Metals in Alzheimer’s Disease through the Use of Surface Enhanced Laser Desorption / Ionisation Time-of-Flight Mass Spectrometry, in Protein Folding, Misfolding, and Disease: Methods and Protocols, A.F. Hill, et al., Editors. Springer.